- Aczél, J.: Lectures on Functional Equations and Their Applications. Academic Press, Cambridge (1966).
Paper not yet in RePEc: Add citation now
- Basu, A., Carlson, J., Veenstra, D.: Health years in total: a new health objective function for cost-effectiveness analysis. Value Health 23(1), 96–103 (2020).
Paper not yet in RePEc: Add citation now
Bleichrodt, H., Quiggin, J.: Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? J. Health Econ. 18(6), 681–708 (1999).
Campbell, J.D., Whittington, M.D., Pearson, S.D.: An alternative measure of health for value assessment: the equal value of life-year. Pharmacoeconomics 41, 1175–1182 (2023).
- Davidson, D., Marschak, J.: Experimental tests of a stochastic decision theory. In: Churchman, C.W., Ratoosh, P. (eds.) Measurement: Definitions and Theories, pp. 420–422. Wiley, New York (1959).
Paper not yet in RePEc: Add citation now
Fleurbaey, M., Ponthiere, G.: The value of a life-year and the intuition of universality. J. Ethics Soc. Philos. 22, 355 (2022).
- Garber, A.M., Phelps, C.E.: Economic foundations of cost-effectiveness analysis. J. Health Econ. 16(1), 1–31 (1997).
Paper not yet in RePEc: Add citation now
- Hasman, A., Østerdal, L.P.: Equal value of life and the pareto principle. Econ. Philos. 20(1), 19–33 (2004).
Paper not yet in RePEc: Add citation now
- Lakdawalla, D.N., Phelps, C.E.: A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE). Eur. J. Health Econ. 23(3), 433–451 (2022).
Paper not yet in RePEc: Add citation now
- Lakdawalla, D.N., Phelps, C.E.: Generalized risk-adjusted cost-effectiveness (GRACE): ensuring patient-centered outcomes in healthcare decision making. Value Outcomes Spotlight 7, S5–S10 (2021).
Paper not yet in RePEc: Add citation now
- Lakdawalla, D.N., Phelps, C.E.: Health technology assessment with diminishing returns to health: the generalized risk-adjusted cost effectiveness (GRACE) approach. Value Health 24(2), 244–249 (2021).
Paper not yet in RePEc: Add citation now
- Lakdawalla, D.N., Phelps, C.E.: Health technology assessment with risk aversion in health. J. Health Econ. 72, 102346 (2020).
Paper not yet in RePEc: Add citation now
Lakdawalla, D.N., Phelps, C.E.: The generalized risk-adjusted cost-effectiveness (GRACE) model for measuring the value of gains in health: an exact formulation. J. Benefit Cost Anal. 14(1), 44–67 (2023).
Moreno-Ternero, J.D., Østerdal, L.P.: Entitlements to continued life and the evaluation of population health. Rev. Econ. Des. 27(3), 561–579 (2023).
Mulligan, K., Baid, D., Doctor, J.N., Phelps, C.E., Lakdawalla, D.N.: Risk preferences over health: empirical estimates and implications for medical decision-making. J Health Econ. (Forthcoming). 2024. https://www.sciencedirect.com/science/article/pii/S016762962400002X .
- Nord, E., et al.: Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ. 8(1), 25–39 (1999).
Paper not yet in RePEc: Add citation now
- Nord, E., et al.: Maximizing health benefits vs egalitarianism: an australian survey of health issues. Soc Sci Med 41(10), 1429–1437 (1995).
Paper not yet in RePEc: Add citation now
- Nord, E., Johansen, R.: Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a Qaly. Health Policy 116(2–3), 281–288 (2014).
Paper not yet in RePEc: Add citation now
Nord, E., Johansen, R.: Transforming Eq-5d utilities for use in cost-value analysis of health programs. Eur. J. Health Econ. 16, 313–328 (2015).
- Nord, E.: The relevance of health state after treatment in prioritising between different patients. J. Med. Ethics 19(1), 37–42 (1993).
Paper not yet in RePEc: Add citation now
- O’Day, K., Mezzio, D.J.: Demystifying Icer’s equal value of life years gained metric. Signal 08 (2022).
Paper not yet in RePEc: Add citation now
- Østerdal, L.P.: A note on cost-value analysis. Health Econ. 12(3), 247–250 (2003).
Paper not yet in RePEc: Add citation now
- Paulden, M., et al.: Are the ‘Equal Value of Life Years Gained’ and ‘Health Years in Total’ Approaches Viable Alternatives to the Qaly? Matters of Logic and Matters of Value. 2020. https://www.canadiancentreforhealtheconomics.ca/announcements/cche-seminar-series-are-the-equal-value-of-life-years-gained-and-health-years-in-total-approaches-viable-alternatives-to-the-qaly-matters-of-logic-and-matters-of/ . Accessed 20 July 2023.
Paper not yet in RePEc: Add citation now
- Pearson, S.D.: Why the coming debate over the Qaly and disability will be different. J. Law Med. Ethics 47(2), 304–307 (2019).
Paper not yet in RePEc: Add citation now
- Pfanzagl, J.: Theory of Measurement, 2nd edn. Physica-Verlag, Wiirzburg (1971).
Paper not yet in RePEc: Add citation now
- Rosen, S.: The value of changes in life expectancy. J. Risk Uncertain. 1(3), 285–304 (1988).
Paper not yet in RePEc: Add citation now
- Seshamani, M.: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191-1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of Comments. 2023, Centers for Medicare and Medicaid Services: Washington, DC.
Paper not yet in RePEc: Add citation now
- Stalmeier, P.F., et al.: On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med. Care 45, 835–841 (2007).
Paper not yet in RePEc: Add citation now
- Sutherland, H.J., et al.: Attitudes toward quality of survival: the concept of “maximal endurable time.” Med. Decis. Mak. 2(3), 299–309 (1982).
Paper not yet in RePEc: Add citation now
Weinstein, M.C.: Challenges for cost-effectiveness research. Med. Decis. Mak. 6(4), 194–198 (1986).
- Whittington, M.D., et al.: Cost-effectiveness and value-based pricing of aducanumab for patients with early Alzheimer disease. Neurology 98(9), e968–e977 (2022).
Paper not yet in RePEc: Add citation now